APA (7th ed.) Citation

Chen, H., Kuo, T., Tseng, C., Ma, J., Yang, S., Yen, C., . . . Su, J. (2016). Angiopoietin‐like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma. Hepatology (Baltimore, Md.), 64(5), 1637-1651. https://doi.org/10.1002/hep.28773

Chicago Style (17th ed.) Citation

Chen, Hsin‐An, Tsang‐Chih Kuo, Chi‐Feng Tseng, Jui‐Ti Ma, Shu‐Ting Yang, Chia‐Jui Yen, Ching‐Yao Yang, Shian‐Ying Sung, and Jen‐Liang Su. "Angiopoietin‐like Protein 1 Antagonizes MET Receptor Activity to Repress Sorafenib Resistance and Cancer Stemness in Hepatocellular Carcinoma." Hepatology (Baltimore, Md.) 64, no. 5 (2016): 1637-1651. https://doi.org/10.1002/hep.28773.

MLA (9th ed.) Citation

Chen, Hsin‐An, et al. "Angiopoietin‐like Protein 1 Antagonizes MET Receptor Activity to Repress Sorafenib Resistance and Cancer Stemness in Hepatocellular Carcinoma." Hepatology (Baltimore, Md.), vol. 64, no. 5, 2016, pp. 1637-1651, https://doi.org/10.1002/hep.28773.